SOGECLAIR (ALSOG.PA) Fundamental Analysis & Valuation

EPA:ALSOGFR0000065864

Current stock price

42 EUR
+1.6 (+3.96%)
Last:

This ALSOG.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. ALSOG.PA Profitability Analysis

1.1 Basic Checks

  • ALSOG had positive earnings in the past year.
  • ALSOG had a positive operating cash flow in the past year.
  • Each year in the past 5 years ALSOG has been profitable.
  • ALSOG had a positive operating cash flow in each of the past 5 years.
ALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

  • ALSOG has a Return On Assets of 3.85%. This is comparable to the rest of the industry: ALSOG outperforms 45.76% of its industry peers.
  • ALSOG has a Return On Equity (11.09%) which is in line with its industry peers.
  • Looking at the Return On Invested Capital, with a value of 10.01%, ALSOG is in the better half of the industry, outperforming 67.80% of the companies in the same industry.
Industry RankSector Rank
ROA 3.85%
ROE 11.09%
ROIC 10.01%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALSOG.PA Yearly ROA, ROE, ROICALSOG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

  • ALSOG has a Profit Margin (3.56%) which is comparable to the rest of the industry.
  • ALSOG's Profit Margin has improved in the last couple of years.
  • The Operating Margin of ALSOG (6.36%) is worse than 64.41% of its industry peers.
  • ALSOG's Operating Margin has improved in the last couple of years.
  • With an excellent Gross Margin value of 59.67%, ALSOG belongs to the best of the industry, outperforming 89.83% of the companies in the same industry.
  • ALSOG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.36%
PM (TTM) 3.56%
GM 59.67%
OM growth 3Y22.34%
OM growth 5YN/A
PM growth 3Y34.5%
PM growth 5YN/A
GM growth 3Y2.82%
GM growth 5Y1.63%
ALSOG.PA Yearly Profit, Operating, Gross MarginsALSOG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 20 40

6

2. ALSOG.PA Health Analysis

2.1 Basic Checks

  • ALSOG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • There is no outstanding debt for ALSOG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALSOG.PA Yearly Shares OutstandingALSOG.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
ALSOG.PA Yearly Total Debt VS Total AssetsALSOG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • ALSOG has an Altman-Z score of 2.89. This is not the best score and indicates that ALSOG is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ALSOG has a Altman-Z score (2.89) which is in line with its industry peers.
  • The Debt to FCF ratio of ALSOG is 1.55, which is an excellent value as it means it would take ALSOG, only 1.55 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.55, ALSOG belongs to the top of the industry, outperforming 86.44% of the companies in the same industry.
  • A Debt/Equity ratio of 0.36 indicates that ALSOG is not too dependend on debt financing.
  • ALSOG has a better Debt to Equity ratio (0.36) than 64.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 1.55
Altman-Z 2.89
ROIC/WACC1.13
WACC8.89%
ALSOG.PA Yearly LT Debt VS Equity VS FCFALSOG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M

2.3 Liquidity

  • ALSOG has a Current Ratio of 1.78. This is a normal value and indicates that ALSOG is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.78, ALSOG is doing good in the industry, outperforming 74.58% of the companies in the same industry.
  • ALSOG has a Quick Ratio of 1.55. This is a normal value and indicates that ALSOG is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.55, ALSOG belongs to the top of the industry, outperforming 83.05% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.55
ALSOG.PA Yearly Current Assets VS Current LiabilitesALSOG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. ALSOG.PA Growth Analysis

3.1 Past

  • ALSOG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.07%, which is quite impressive.
  • ALSOG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.55% yearly.
  • Looking at the last year, ALSOG shows a small growth in Revenue. The Revenue has grown by 2.08% in the last year.
  • The Revenue has been growing slightly by 5.43% on average over the past years.
EPS 1Y (TTM)29.07%
EPS 3Y42.55%
EPS 5YN/A
EPS Q2Q%12.82%
Revenue 1Y (TTM)2.08%
Revenue growth 3Y5.91%
Revenue growth 5Y5.43%
Sales Q2Q%2.3%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.48% on average over the next years. This is quite good.
  • Based on estimates for the next years, ALSOG will show a small growth in Revenue. The Revenue will grow by 5.23% on average per year.
EPS Next Y13.02%
EPS Next 2Y14.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.65%
Revenue Next 2Y5.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ALSOG.PA Yearly Revenue VS EstimatesALSOG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALSOG.PA Yearly EPS VS EstimatesALSOG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

6

4. ALSOG.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALSOG is valuated rather expensively with a Price/Earnings ratio of 22.46.
  • 89.83% of the companies in the same industry are more expensive than ALSOG, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.18, ALSOG is valued at the same level.
  • A Price/Forward Earnings ratio of 16.18 indicates a correct valuation of ALSOG.
  • Based on the Price/Forward Earnings ratio, ALSOG is valued cheaper than 100.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of ALSOG to the average of the S&P500 Index (37.96), we can say ALSOG is valued rather cheaply.
Industry RankSector Rank
PE 22.46
Fwd PE 16.18
ALSOG.PA Price Earnings VS Forward Price EarningsALSOG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • ALSOG's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ALSOG is cheaper than 100.00% of the companies in the same industry.
  • ALSOG's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALSOG is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.14
EV/EBITDA 7.26
ALSOG.PA Per share dataALSOG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • ALSOG's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of ALSOG may justify a higher PE ratio.
  • ALSOG's earnings are expected to grow with 14.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.73
PEG (5Y)N/A
EPS Next 2Y14.48%
EPS Next 3YN/A

4

5. ALSOG.PA Dividend Analysis

5.1 Amount

  • ALSOG has a Yearly Dividend Yield of 2.48%.
  • ALSOG's Dividend Yield is rather good when compared to the industry average which is at 0.69. ALSOG pays more dividend than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ALSOG pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.48%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
ALSOG.PA Yearly Dividends per shareALSOG.PA Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • ALSOG pays out 51.33% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP51.33%
EPS Next 2Y14.48%
EPS Next 3YN/A
ALSOG.PA Yearly Income VS Free CF VS DividendALSOG.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 0 10M -10M 20M
ALSOG.PA Dividend Payout.ALSOG.PA Dividend Payout, showing the Payout Ratio.ALSOG.PA Dividend Payout.PayoutRetained Earnings

ALSOG.PA Fundamentals: All Metrics, Ratios and Statistics

SOGECLAIR

EPA:ALSOG (4/13/2026, 7:00:00 PM)

42

+1.6 (+3.96%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)03-11
Earnings (Next)04-29
Inst Owners6.1%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap134.40M
Revenue(TTM)160.28M
Net Income(TTM)5.71M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.48%
Yearly Dividend0.94
Dividend Growth(5Y)N/A
DP51.33%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 22.46
Fwd PE 16.18
P/S 0.84
P/FCF 8.14
P/OCF 7.17
P/B 2.61
P/tB 4.4
EV/EBITDA 7.26
EPS(TTM)1.87
EY4.45%
EPS(NY)2.6
Fwd EY6.18%
FCF(TTM)5.16
FCFY12.29%
OCF(TTM)5.86
OCFY13.95%
SpS50.09
BVpS16.09
TBVpS9.54
PEG (NY)1.73
PEG (5Y)N/A
Graham Number26.02
Profitability
Industry RankSector Rank
ROA 3.85%
ROE 11.09%
ROCE 11.41%
ROIC 10.01%
ROICexc 13.51%
ROICexgc 19.77%
OM 6.36%
PM (TTM) 3.56%
GM 59.67%
FCFM 10.31%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y22.34%
OM growth 5YN/A
PM growth 3Y34.5%
PM growth 5YN/A
GM growth 3Y2.82%
GM growth 5Y1.63%
F-Score8
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 1.55
Debt/EBITDA 0.99
Cap/Depr 25.86%
Cap/Sales 1.39%
Interest Coverage 7.25
Cash Conversion 99.53%
Profit Quality 289.1%
Current Ratio 1.78
Quick Ratio 1.55
Altman-Z 2.89
F-Score8
WACC8.89%
ROIC/WACC1.13
Cap/Depr(3y)32.48%
Cap/Depr(5y)229.44%
Cap/Sales(3y)1.21%
Cap/Sales(5y)2.26%
Profit Quality(3y)253.8%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.07%
EPS 3Y42.55%
EPS 5YN/A
EPS Q2Q%12.82%
EPS Next Y13.02%
EPS Next 2Y14.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.08%
Revenue growth 3Y5.91%
Revenue growth 5Y5.43%
Sales Q2Q%2.3%
Revenue Next Year5.65%
Revenue Next 2Y5.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.83%
EBIT growth 3Y29.57%
EBIT growth 5YN/A
EBIT Next Year110.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8%
FCF growth 3YN/A
FCF growth 5Y-5.5%
OCF growth 1Y10.07%
OCF growth 3Y80.31%
OCF growth 5Y-6.21%

SOGECLAIR / ALSOG.PA Fundamental Analysis FAQ

What is the fundamental rating for ALSOG stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALSOG.PA.


What is the valuation status of SOGECLAIR (ALSOG.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to SOGECLAIR (ALSOG.PA). This can be considered as Fairly Valued.


How profitable is SOGECLAIR (ALSOG.PA) stock?

SOGECLAIR (ALSOG.PA) has a profitability rating of 6 / 10.


What is the financial health of SOGECLAIR (ALSOG.PA) stock?

The financial health rating of SOGECLAIR (ALSOG.PA) is 6 / 10.


Can you provide the dividend sustainability for ALSOG stock?

The dividend rating of SOGECLAIR (ALSOG.PA) is 4 / 10 and the dividend payout ratio is 51.33%.